Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2123-2132
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2123
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2123
No LARS (n = 51) | LARS (n = 171) | P value | |
Physical function: High/low | 36 (70.6%)/15 (29.4%) | 87 (50.6%)/85 (49.4%) | 0.0081 |
Role function: High/low | 33 (64.7%)/18 (35.3%) | 88 (51.5%)/84 (48.5%) | 0.06 |
Emotional function: High/low | 38 (74.5%)/13 (25.5%) | 98 (56.9%)/74 (43.1%0 | 0.0172 |
Cognitive function: High/low | 36 (70.6%)/15 (29.4%) | 75 (43.8%)/97 (56.2%) | 0.0011 |
Total health status: High/low | 29 (56.9%)/22 (43.1%) | 69 (40.3%)/103 (59.7%) | 0.0262 |
Fatigue: High/low | 33 (64.7%)/18 (35.3%) | 86 (50%)/86 (50%) | 0.0452 |
Nausea and vomiting: High/low | 45 (88.2%)/6 (11.8%) | 146 (84.9%)/26 (15.1%) | 0.365 |
Pain: High/low | 44 (86.3%)/7 (13.7%) | 109 (63.4%)/63 (36.6%) | 0.0011 |
Polypnea: High/low | 46 (90.2%)/5 (9.8%) | 129 (75.0%)/43 (25%) | 0.0132 |
Sleeplessness: High/low | 40 (78.4%)/11 (21.6%) | 93 (54.1%)/79 (45.9%) | 0.0011 |
Appetite loss: High/low | 42 (82.3%)/9 (17.6%) | 126 (73.3%)/46 (26.7%) | 0.126 |
Constipation: High/low | 35 (68.6%)/16 (31.4%) | 71 (41.3%)/101 (58.7%) | 0.0011 |
Diarrhea: High/low | 41 (80.4%)/10 (19.6%) | 77 (44.8%)/95 (57.2%) | 0.0011 |
Financial difficulty: High/low | 46 (90.2%)/5 (9.8%) | 142 (82.5%)/30 (17.5%) | 0.135 |
Without LARS (n = 51) | With LARS (n = 171) | P value | |
Frequent micturition: With/without | 27 (52.3%)/24 (47.9%) | 74 (43.0%)/98 (56.9%) | 0.138 |
Blood in stool: With/without | 41 (80/4%)/10 (19.6%) | 106 (61.6%)/66 (38.4%) | 0.0091 |
Body image: With/without | 41 (80/4%)/10 (19.6%) | 88 (51.2%)/84 (48.8%) | 0.0011 |
Male sexual function: With/without | 16 (44.4%)/20 (55.6%) | 60 (53.6%)/52 (46.4%) | 0.223 |
Impotence: With/without | 21 (61.7%)/13 (38.3%) | 52 (50%)/52 (50%) | 0.160 |
Female sexual function: With/without | 9 (81.8%)/2 (18.2%) | 37 (80.4%)/9 (19.6%) | 0.644 |
Pain: With/without | 8 (88.8%)/1 (11.1%) | 33 (78.6%)/9 (21.4%) | 0.429 |
Uroclepsia: With/without | 49 (96.1%)/2 (3.9%) | 149 (86.6%)/23 (13.3%) | 0.061 |
Odynuria: With/without | 47 (92.1%)/4 (7.8%) | 157 (91.3%)/15 (8.7%) | 0.816 |
Stomachache: With/without | 44 (86.3%)/7 (13.7%) | 129 (75.0%)/43 (25.0%) | 0.062 |
Pygalgia: With/without | 48 (94.1%)/3 (5.9%) | 128 (74.4%)/44 (25.6%) | 0.0011 |
Ventosity: With/without | 44 (86.3%)/7 (13.7%) | 110 (63.9%)/62 (36.1%) | 0.0011 |
Thirst: With/without | 32 (19.6%)/19 (37.2%) | 83 (48.3%)/89 (51.2%) | 0.0481 |
Alopecia: With/without | 47 (92.2%)/4 (7.8%) | 118 (68.6%)/54 (31.4%) | 0.0011 |
Allotriogeustia: With/without | 46 (90.2%)/5 (9.8%) | 114 (66.3%)/28 (33.8%) | 0.180 |
Anxiety: With/without | 29 (56.9%)/22 (43.1%) | 54 (31.3%)/118 (68.6%) | 0.0011 |
Obesity: With/without | 35 (68.6%)/16 (31.3%) | 97 (56.4%)/75 (43.6%) | 0.081 |
Low LARS score (n = 99) | High LARS score (n = 124) | P value | |
Age (yr): < 59/≥ 60 | 49 (49.5%)/50 (50.5%) | 62 (50.0%)/62 (50.0%) | 0.524 |
Sex: Male/female | 73 (73.4%)/26 (26.3%) | 81 (65.3%)/43 (34.6%) | 0.114 |
Tumor size (cm): < 4/≥ 4 | 44 (44.4%)/52 (55.6%) | 69 (55.6%)/49 (44.4%) | 0.044 |
Length (cm): < 12/≥ 12 | 25 (25.3%)/63 (74.7%) | 25 (23.1%)/83 (76.8%) | 0.249 |
Length of distal margin (cm): < 3/≥ 3 | 43 (52.4%)/39 (47.6%) | 52 (57.1%)/39 (42.8%) | 0.32 |
T: 0, 1/2, 3 | 10 (15.1%)/56 (84.8%) | 13 (17.6%)61 (82.4%) | 0.439 |
N: < 17/≥ 17 | 60 (61.8%)/37 (38.1%) | 77 (63.1%)/45 (36.9%0 | 0.479 |
M: No/yes | 86 (92.5%)/7 (7.5%) | 86 (89.6%)/10 (10.4%) | 0.331 |
Differentiated degree: 0, 1/2, 3 | 31 (31.9%)/66 (68.1%0 | 45 (37.8%)/74 (62.2%) | 0.264 |
TME/PME | 59 (62.1%)/39 (37.9%) | 58 (47.5%)/64 (52.4%) | 0.041 |
Anal distance: < 9/≥ 9(cm) | 41 (41.8%)/57 (58.2%) | 62 (51%)/60 (49%) | 0.117 |
Fistulation: No/yes | 53 (53.5%)/46 (46.5%) | 50 (41.3%)/71 (58.7%) | 0.005 |
Preoperation radiotherapy: No/yes | 79 (81.4%)/18 (18.6%) | 79 (64.7%)/43 (35.1%) | 0.0211 |
Neoadjuvant chemotherapy: No/yes | 84 (85.7%)/14 (24.3%) | 84 (68.3%)/39 (31.7%) | 0.0072 |
- Citation: Jin DA, Gu FP, Meng TL, Zhang XX. Effect of low anterior resection syndrome on quality of life in colorectal cancer patients: A retrospective observational study. World J Gastrointest Surg 2023; 15(10): 2123-2132
- URL: https://www.wjgnet.com/1948-9366/full/v15/i10/2123.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i10.2123